Theresa Coles
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Theresa Coles has a total of 254 co-authors. Here are the top co-authors by number of shared publications:
Bryce B. Reeve
Center for Health Measurement, Department of Population Health Sciences, Duke University School of Medicine, Durham, USA
10 shared publicationsBrittany Caldwell
Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, USA
5 shared publicationsIleana L. Piña
Wayne State University, Central Michigan University, Mount Pleasant, USA
5 shared publicationsKevin Weinfurt
Center for Health Measurement, Department of Population Health Sciences, Duke University School of Medicine, Durham, USA
5 shared publicationsMichelle E. Tarver
Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, USA
5 shared publicationsAnindita Saha
Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, USA
4 shared publications
Latest Publications
- 25 July 2026
- Published by Springer Nature in The Patient - Patient-Centered Outcomes Research
- Vol. 19 (6) , 753-756
Extending the Interpretation of Patient-Reported Outcome Scores through Patient-Preference Information
- 25 July 2026
- Published by Springer Nature in The Patient - Patient-Centered Outcomes Research
- Vol. 19 (6) , 753-756
Extending the Interpretation of Patient-Reported Outcome Scores through Patient-Preference Information
- Open Access
- 19 January 2026
- Published by SAGE Publications in International Journal of Qualitative Methods
- Vol. 25
The THINK-TTP Study for Assessing Cognitive Function in Clinical Trials: A Qualitative Research Protocol
Purpose of the Research: Immune thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening condition with long-term impacts on survivors’ health-related quality of life (HRQoL). A top HRQoL concern among TTP survivors is cognitive dysfunction. However, the specific cognitive aspects affected by TTP remain poorly understood. This gap limits the ability to assess cognitive outcomes in clinical trials and hinders the development of targeted interventions. To address this gap, we designed THINK-TTP – a qualitative study designed to identify and characterize cognitive dysfunction experienced by patients with TTP through interviews with patients and patient-observer dyads. Major Findings: This protocol describes a multi-site, descriptive, qualitative study of cognitive dysfunction using semi-structured interviews of 24 patient and close observer dyads (48 interviews total). This study is the first step in selection of appropriate clinical outcome assessments that are specific to cognitive dysfunction experienced after a TTP diagnosis. Additional data sources include standardized questionnaires, clinical data, and performance-based cognitive tasks. Conclusions: A qualitative study protocol describing procedures for eliciting and documenting patient and observer perspectives on cognitive function facilitates rigor and transparency and enhances clinical trial readiness. After completion, this study will generate foundational evidence to support cognitive function measures tailored to the experiences of people with TTP in clinical trials.
- 19 January 2026
- Published by SAGE Publications in International Journal of Qualitative Methods
- Vol. 25
Open AccessThe THINK-TTP Study for Assessing Cognitive Function in Clinical Trials: A Qualitative Research Protocol
Purpose of the Research: Immune thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening condition with long-term impacts on survivors’ health-related quality of life (HRQoL). A top HRQoL concern among TTP survivors is cognitive dysfunction. However, the specific cognitive aspects affected by TTP remain poorly understood. This gap limits the ability to assess cognitive outcomes in clinical trials and hinders the development of targeted interventions. To address this gap, we designed THINK-TTP – a qualitative study designed to identify and characterize cognitive dysfunction experienced by patients with TTP through interviews with patients and patient-observer dyads. Major Findings: This protocol describes a multi-site, descriptive, qualitative study of cognitive dysfunction using semi-structured interviews of 24 patient and close observer dyads (48 interviews total). This study is the first step in selection of appropriate clinical outcome assessments that are specific to cognitive dysfunction experienced after a TTP diagnosis. Additional data sources include standardized questionnaires, clinical data, and performance-based cognitive tasks. Conclusions: A qualitative study protocol describing procedures for eliciting and documenting patient and observer perspectives on cognitive function facilitates rigor and transparency and enhances clinical trial readiness. After completion, this study will generate foundational evidence to support cognitive function measures tailored to the experiences of people with TTP in clinical trials.
- Open Access
- 19 January 2026
- Published by Wiley in ACR Open Rheumatology
- Vol. 8 (1) , e70155
Transitions in Psychological Distress Phenotypes and Patient‐Reported Outcomes Among Patients Undergoing Total Joint Arthroplasty
Psychological distress is common in individuals undergoing total joint arthroplasty (TJA). Understanding psychological phenotypes and their transitions from before to after surgery can inform risk stratification and targeted care. This study aimed to characterize psychological phenotypes, examine transitions, and compare patient outcomes across phenotypes. This retrospective study included 494 patients who underwent primary hip (43%) or knee (57%) arthroplasty at Duke University Health System (2018–2024). Latent transition analysis identified and examined transitions of psychological phenotypes preoperatively and postoperatively using the Optimal Screening for Prediction of Referral and Outcome Yellow Flag tool. Demographic characteristics, phenotype transitions, Patient‐Reported Outcomes Measurement Information System (PROMIS) Pain Interference (PI), PROMIS Physical Function (PF), pain intensity, and high‐impact chronic pain (HICP) were compared across phenotypes. The optimal model fit was a constrained model comprising five classes: class 1 (low self‐efficacy with poor pain coping), class 2 (low distress), class 3 (poor pain coping), class 4 (high distress), and class 5 (low self‐efficacy with acceptance). Most patients (n = 271, 55%) transitioned to a different phenotype. The probabilities for remaining in the same class ranged from 0.19 (poor pain coping) to 0.61 (low distress). The incidence of high distress was 6% within 12 months after TJA. High distress was associated with lower PROMIS‐PF and higher PROMIS‐PI scores, pain intensity, and prevalence of HICP (P < 0.001). Transitions were observed across all phenotypes, with some demonstrating greater stability and others showing more state‐like variability. Identifying phenotypes with distinct trajectories and outcomes may support targeted screening and preoperative risk stratification.
- 19 January 2026
- Published by Wiley in ACR Open Rheumatology
- Vol. 8 (1) , e70155
Open AccessTransitions in Psychological Distress Phenotypes and Patient‐Reported Outcomes Among Patients Undergoing Total Joint Arthroplasty
Psychological distress is common in individuals undergoing total joint arthroplasty (TJA). Understanding psychological phenotypes and their transitions from before to after surgery can inform risk stratification and targeted care. This study aimed to characterize psychological phenotypes, examine transitions, and compare patient outcomes across phenotypes. This retrospective study included 494 patients who underwent primary hip (43%) or knee (57%) arthroplasty at Duke University Health System (2018–2024). Latent transition analysis identified and examined transitions of psychological phenotypes preoperatively and postoperatively using the Optimal Screening for Prediction of Referral and Outcome Yellow Flag tool. Demographic characteristics, phenotype transitions, Patient‐Reported Outcomes Measurement Information System (PROMIS) Pain Interference (PI), PROMIS Physical Function (PF), pain intensity, and high‐impact chronic pain (HICP) were compared across phenotypes. The optimal model fit was a constrained model comprising five classes: class 1 (low self‐efficacy with poor pain coping), class 2 (low distress), class 3 (poor pain coping), class 4 (high distress), and class 5 (low self‐efficacy with acceptance). Most patients (n = 271, 55%) transitioned to a different phenotype. The probabilities for remaining in the same class ranged from 0.19 (poor pain coping) to 0.61 (low distress). The incidence of high distress was 6% within 12 months after TJA. High distress was associated with lower PROMIS‐PF and higher PROMIS‐PI scores, pain intensity, and prevalence of HICP (P < 0.001). Transitions were observed across all phenotypes, with some demonstrating greater stability and others showing more state‐like variability. Identifying phenotypes with distinct trajectories and outcomes may support targeted screening and preoperative risk stratification.
- 1 January 2026
- Published by Human Kinetics in Journal of Physical Activity and Health
- Vol. 23 (8) , 1-8
Physical Activity Versus Exercise: Patient Perspectives on Word Choice in Clinic-Based Physical Activity Screening Questionnaire Prompts
Purpose : Physical activity (PA) is an important component of health, yet PA screening is not broadly adopted in clinical practice. Screening tools present trade-offs between efficiency and comprehensiveness, and patient understanding and interpretation of terms like “physical activity” and “exercise” may influence reporting. We aimed to describe how patients interpret and report these terms in primary care. Methods : We conducted a survey-based study with English- and Spanish-speaking participants. Four open-ended questions asked participants to define “exercise” and “physical activity” and describe their own PA and exercise in the past week. Thirteen close-ended questions asked participants to classify activities. Responses were analyzed qualitatively and descriptively. Results : Of 142 participants, most defined PA broadly as movement , while exercise was described as intentional movement with a purpose . When describing PA, Spanish speakers less often included housework and yardwork and more often considered job-related activity as exercise. Many classified occupational and household activities as PA but not exercise. About one quarter viewed transportation-related activities as exercise only. Recreational activities were frequently classified as both, though many participants considered structured moderate- and high-intensity activities as exercise only. Conclusion : Patients view PA and exercise as overlapping but distinct constructs, highlighting the importance of terminology in PA screening.
- 1 January 2026
- Published by Human Kinetics in Journal of Physical Activity and Health
- Vol. 23 (8) , 1-8
Physical Activity Versus Exercise: Patient Perspectives on Word Choice in Clinic-Based Physical Activity Screening Questionnaire Prompts
Purpose : Physical activity (PA) is an important component of health, yet PA screening is not broadly adopted in clinical practice. Screening tools present trade-offs between efficiency and comprehensiveness, and patient understanding and interpretation of terms like “physical activity” and “exercise” may influence reporting. We aimed to describe how patients interpret and report these terms in primary care. Methods : We conducted a survey-based study with English- and Spanish-speaking participants. Four open-ended questions asked participants to define “exercise” and “physical activity” and describe their own PA and exercise in the past week. Thirteen close-ended questions asked participants to classify activities. Responses were analyzed qualitatively and descriptively. Results : Of 142 participants, most defined PA broadly as movement , while exercise was described as intentional movement with a purpose . When describing PA, Spanish speakers less often included housework and yardwork and more often considered job-related activity as exercise. Many classified occupational and household activities as PA but not exercise. About one quarter viewed transportation-related activities as exercise only. Recreational activities were frequently classified as both, though many participants considered structured moderate- and high-intensity activities as exercise only. Conclusion : Patients view PA and exercise as overlapping but distinct constructs, highlighting the importance of terminology in PA screening.
- Open Access
- 6 November 2025
- Published by Springer Nature in Journal of Patient-Reported Outcomes
- Vol. 9 (1) , 1-10
Development of the Sinus Headache Screener to identify patients with non-rhinogenic facial pain compared with chronic rhinosinusitis in rhinology clinics
Purpose: To develop a patient-reported screening tool, the Sinus Headache Screener (SHS), to differentiate non-rhinogenic facial pain (NRFP) from chronic rhinosinusitis (CRS) using qualitative research methods. Methods: We conducted semi-structured interviews with 26 English-speaking adults (15 NRFP, 11 CRS). Interviews included concept elicitation and cognitive interviewing techniques. Content analysis was used to analyze transcripts, and items were iteratively refined over three rounds of interviews. Results: The final list of potential SHS items consisted of 89 items across 8 sections, including symptoms, episode characteristics, triggers, and treatments. Conclusions: This study represents the first step in developing a screening questionnaire to identify patients with NRFP in clinical settings. The item list provides a foundation for future quantitative studies to refine the questionnaire, potentially leading to more appropriate diagnosis and treatment of patients presenting with facial pain or pressure.
- 6 November 2025
- Published by Springer Nature in Journal of Patient-Reported Outcomes
- Vol. 9 (1) , 1-10
Open AccessDevelopment of the Sinus Headache Screener to identify patients with non-rhinogenic facial pain compared with chronic rhinosinusitis in rhinology clinics
Purpose: To develop a patient-reported screening tool, the Sinus Headache Screener (SHS), to differentiate non-rhinogenic facial pain (NRFP) from chronic rhinosinusitis (CRS) using qualitative research methods. Methods: We conducted semi-structured interviews with 26 English-speaking adults (15 NRFP, 11 CRS). Interviews included concept elicitation and cognitive interviewing techniques. Content analysis was used to analyze transcripts, and items were iteratively refined over three rounds of interviews. Results: The final list of potential SHS items consisted of 89 items across 8 sections, including symptoms, episode characteristics, triggers, and treatments. Conclusions: This study represents the first step in developing a screening questionnaire to identify patients with NRFP in clinical settings. The item list provides a foundation for future quantitative studies to refine the questionnaire, potentially leading to more appropriate diagnosis and treatment of patients presenting with facial pain or pressure.
- Open Access
- 4 December 2024
- Published by Springer Nature in Quality of Life Research
- Vol. 34 (3) , 857-866
Recalling what we thought we knew about recall periods: a qualitative descriptive study of how adults diagnosed with cancer use recall periods for patient-reported outcome items about physical function
Objectives In cancer studies, assessment of patients’ physical function can provide insight into cancer-related symptoms and the side effects of treatment. Physical function can be assessed using patient-reported outcome measures (PROMs), which may or may not include a recall period—the amount of time the questionnaire asks the respondent to think back to answer the questions. More understanding is needed about how patients interpret and respond to items posed with different recall periods, and which recall period they actually use. Study Design and Setting We conducted a qualitative study with 72 adults diagnosed with cancer to describe response processes when answering PROM items about physical function. Results When describing their physical function during concept elicitation interviews, most participants recalled their functioning over 1 month or more. When presented with PROM items with no recall period, the most used period was more than 4 weeks. When presented with a 7-day recall, the most used period was 7 days. However, almost 30% of responses used recall periods greater than 1 week. Conclusion Including a 7-day recall period improves recall consistency for patients when answering physical function PROM items, but there is still room for improvement. The inaccuracy of recall for PROMs in clinical trials influences the ability to calculate the change in treatment outcomes over time and may conceal or emphasize actual treatment effects.
- 4 December 2024
- Published by Springer Nature in Quality of Life Research
- Vol. 34 (3) , 857-866
Open AccessRecalling what we thought we knew about recall periods: a qualitative descriptive study of how adults diagnosed with cancer use recall periods for patient-reported outcome items about physical function
Objectives In cancer studies, assessment of patients’ physical function can provide insight into cancer-related symptoms and the side effects of treatment. Physical function can be assessed using patient-reported outcome measures (PROMs), which may or may not include a recall period—the amount of time the questionnaire asks the respondent to think back to answer the questions. More understanding is needed about how patients interpret and respond to items posed with different recall periods, and which recall period they actually use. Study Design and Setting We conducted a qualitative study with 72 adults diagnosed with cancer to describe response processes when answering PROM items about physical function. Results When describing their physical function during concept elicitation interviews, most participants recalled their functioning over 1 month or more. When presented with PROM items with no recall period, the most used period was more than 4 weeks. When presented with a 7-day recall, the most used period was 7 days. However, almost 30% of responses used recall periods greater than 1 week. Conclusion Including a 7-day recall period improves recall consistency for patients when answering physical function PROM items, but there is still room for improvement. The inaccuracy of recall for PROMs in clinical trials influences the ability to calculate the change in treatment outcomes over time and may conceal or emphasize actual treatment effects.
- 1 June 2024
- Published by American Society of Clinical Oncology (ASCO) in JCO Oncology Practice
- Vol. 20 (6) , 835-842
Mixed-Methods Study on the Responsiveness of the Comprehensive Score for Financial Toxicity Among People With Multiple Myeloma
PURPOSE: Financial toxicity is a contributor to the psychosocial burden of cancer care. There is no consensus measure of financial toxicity; however, recent studies have adopted the Comprehensive Score for Financial Toxicity (COST). Despite its growing popularity, data on the responsiveness to change of the COST instrument are lacking. To address this gap in the literature, we performed a sequential mixed-methods study of people with multiple myeloma. MATERIALS AND METHODS: In the quantitative phase of the study, we collected COST scores at two time points approximately 8 weeks apart from 72 patients. In the qualitative phase, we conducted semistructured interviews with a subset of 12 patients who reported the largest changes in scores. The qualitative data were analyzed using a deductive coding scheme developed using the Framework Method in the context of a commonly cited conceptual model of financial toxicity. RESULTS: The median absolute change in COST scores was four points (IQR, 2-6). Only 13% of the sample had the same COST scores at both assessments; 38% had an improved score and 50% had a worsened score. Only, seven of the 12 patients (58%) interviewed reported changes to one or more of the constructs in the conceptual model of financial toxicity. Most commonly, changes to out-of-pocket medical costs were reported (5/12). Changes to nonmedical expenses (n = 2) and subjective financial distress without changes to objective financial burden (n = 2) were also reported. CONCLUSION: Additional research is needed to explicate changes in COST scores over time.
- 1 June 2024
- Published by American Society of Clinical Oncology (ASCO) in JCO Oncology Practice
- Vol. 20 (6) , 835-842
Mixed-Methods Study on the Responsiveness of the Comprehensive Score for Financial Toxicity Among People With Multiple Myeloma
PURPOSE: Financial toxicity is a contributor to the psychosocial burden of cancer care. There is no consensus measure of financial toxicity; however, recent studies have adopted the Comprehensive Score for Financial Toxicity (COST). Despite its growing popularity, data on the responsiveness to change of the COST instrument are lacking. To address this gap in the literature, we performed a sequential mixed-methods study of people with multiple myeloma. MATERIALS AND METHODS: In the quantitative phase of the study, we collected COST scores at two time points approximately 8 weeks apart from 72 patients. In the qualitative phase, we conducted semistructured interviews with a subset of 12 patients who reported the largest changes in scores. The qualitative data were analyzed using a deductive coding scheme developed using the Framework Method in the context of a commonly cited conceptual model of financial toxicity. RESULTS: The median absolute change in COST scores was four points (IQR, 2-6). Only 13% of the sample had the same COST scores at both assessments; 38% had an improved score and 50% had a worsened score. Only, seven of the 12 patients (58%) interviewed reported changes to one or more of the constructs in the conceptual model of financial toxicity. Most commonly, changes to out-of-pocket medical costs were reported (5/12). Changes to nonmedical expenses (n = 2) and subjective financial distress without changes to objective financial burden (n = 2) were also reported. CONCLUSION: Additional research is needed to explicate changes in COST scores over time.
- 15 May 2024
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 51 (8) , 759-764
Evaluating Factors Associated With Telehealth Appropriateness in Outpatient Rheumatoid Arthritis Encounters Using the Encounter Appropriateness Score for You (EASY)
Objective: Telehealth has been proposed as a safe and effective alternative to in-person care for rheumatoid arthritis (RA). The purpose of this study was to evaluate factors associated with telehealth appropriateness in outpatient RA encounters.Methods: A prospective cohort study (January 1, 2021, to August 31, 2021) was conducted using electronic health record data from outpatient RA encounters in a single academic rheumatology practice. Rheumatology providers rated the telehealth appropriateness of their own encounters using the Encounter Appropriateness Score for You (EASY) immediately following each encounter. Robust Poisson regression with generalized estimating equations modeling was used to evaluate the association of telehealth appropriateness with patient demographics, RA clinical characteristics, comorbid noninflammatory causes of joint pain, previous and current encounter characteristics, and provider characteristics.Results: During the study period, 1823 outpatient encounters with 1177 unique patients with RA received an EASY score from 25 rheumatology providers. In the final multivariate model, factors associated with increased telehealth appropriateness included higher average provider preference for telehealth in prior encounters (relative risk [RR] 1.26, 95% CI 1.21-1.31), telehealth as the current encounter modality (RR 2.27, 95% CI 1.95-2.64), and increased patient age (RR 1.05, 95% CI 1.01-1.09). Factors associated with decreased telehealth appropriateness included moderate (RR 0.81, 95% CI 0.68-0.96) and high (RR 0.57, 95% CI 0.46-0.70) RA disease activity and if the previous encounters were conducted by telehealth (RR 0.83, 95% CI 0.73-0.95).Conclusion: In this study, telehealth appropriateness was most associated with provider preference, the current and previous encounter modality, and RA disease activity. Other factors like patient demographics, RA medications, and comorbid noninflammatory causes of joint pain were not associated with telehealth appropriateness.
- 15 May 2024
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 51 (8) , 759-764
Evaluating Factors Associated With Telehealth Appropriateness in Outpatient Rheumatoid Arthritis Encounters Using the Encounter Appropriateness Score for You (EASY)
Objective: Telehealth has been proposed as a safe and effective alternative to in-person care for rheumatoid arthritis (RA). The purpose of this study was to evaluate factors associated with telehealth appropriateness in outpatient RA encounters.Methods: A prospective cohort study (January 1, 2021, to August 31, 2021) was conducted using electronic health record data from outpatient RA encounters in a single academic rheumatology practice. Rheumatology providers rated the telehealth appropriateness of their own encounters using the Encounter Appropriateness Score for You (EASY) immediately following each encounter. Robust Poisson regression with generalized estimating equations modeling was used to evaluate the association of telehealth appropriateness with patient demographics, RA clinical characteristics, comorbid noninflammatory causes of joint pain, previous and current encounter characteristics, and provider characteristics.Results: During the study period, 1823 outpatient encounters with 1177 unique patients with RA received an EASY score from 25 rheumatology providers. In the final multivariate model, factors associated with increased telehealth appropriateness included higher average provider preference for telehealth in prior encounters (relative risk [RR] 1.26, 95% CI 1.21-1.31), telehealth as the current encounter modality (RR 2.27, 95% CI 1.95-2.64), and increased patient age (RR 1.05, 95% CI 1.01-1.09). Factors associated with decreased telehealth appropriateness included moderate (RR 0.81, 95% CI 0.68-0.96) and high (RR 0.57, 95% CI 0.46-0.70) RA disease activity and if the previous encounters were conducted by telehealth (RR 0.83, 95% CI 0.73-0.95).Conclusion: In this study, telehealth appropriateness was most associated with provider preference, the current and previous encounter modality, and RA disease activity. Other factors like patient demographics, RA medications, and comorbid noninflammatory causes of joint pain were not associated with telehealth appropriateness.
- 20 April 2024
- Published by Springer Nature in Quality of Life Research
- Vol. 33 (7) , 1829-1839
What facets of physical function are most important to adults diagnosed with cancer?
Purpose Successful patient-focused drug development involves selecting and measuring outcomes in clinical trials that are important to patients. The U.S. Food & Drug Administration’s definition of clinical benefit includes how patients feel, function, or survive. Patients are considered the experts in describing how they feel and function. In cancer trials, patient-reported measures of physical function provide insight into how patients function at baseline, benefit from the interventions being studied, and the impact of treatment side effects. We conducted a qualitative study with adults diagnosed with cancer to describe facets of physical function from their perspective and to identify which facets are most important to this patient population. Methods Using concept elicitation and cognitive interviewing techniques, we conducted semi-structured interviews with 72 adults ≥ 22 years of age with cancer who received treatment with an anticancer drug or biologic within six months of the interview. We selected participants using purposive sampling with the aim to elicit diverse experiences regarding how they may interpret and respond to questions related to physical function. Participants were presented with patient-reported outcome (PRO) items representative of PRO measures used in cancer and general populations. Results Five facets of how physical function relates to activities were defined from the patient perspective: ability, difficulty, limitation, satisfaction, and completion. More than half of the participants indicated that ability was the most important facet of physical function. The next most important were satisfaction (18.3%), limitation (14.1%), difficulty (5.6%), and completion (2.8%). Conclusion This study demonstrates that we must be more specific about the facets of physical function that we set out to assess when we use PRO measures to describe the patient experience. These results have implications for the specificity of physical function facets when measured in cancer clinical trials.
- 20 April 2024
- Published by Springer Nature in Quality of Life Research
- Vol. 33 (7) , 1829-1839
What facets of physical function are most important to adults diagnosed with cancer?
Purpose Successful patient-focused drug development involves selecting and measuring outcomes in clinical trials that are important to patients. The U.S. Food & Drug Administration’s definition of clinical benefit includes how patients feel, function, or survive. Patients are considered the experts in describing how they feel and function. In cancer trials, patient-reported measures of physical function provide insight into how patients function at baseline, benefit from the interventions being studied, and the impact of treatment side effects. We conducted a qualitative study with adults diagnosed with cancer to describe facets of physical function from their perspective and to identify which facets are most important to this patient population. Methods Using concept elicitation and cognitive interviewing techniques, we conducted semi-structured interviews with 72 adults ≥ 22 years of age with cancer who received treatment with an anticancer drug or biologic within six months of the interview. We selected participants using purposive sampling with the aim to elicit diverse experiences regarding how they may interpret and respond to questions related to physical function. Participants were presented with patient-reported outcome (PRO) items representative of PRO measures used in cancer and general populations. Results Five facets of how physical function relates to activities were defined from the patient perspective: ability, difficulty, limitation, satisfaction, and completion. More than half of the participants indicated that ability was the most important facet of physical function. The next most important were satisfaction (18.3%), limitation (14.1%), difficulty (5.6%), and completion (2.8%). Conclusion This study demonstrates that we must be more specific about the facets of physical function that we set out to assess when we use PRO measures to describe the patient experience. These results have implications for the specificity of physical function facets when measured in cancer clinical trials.
- 20 April 2024
- Published by Springer Nature in Quality of Life Research
- Vol. 33 (7) , 1819-1828
Facets of physical function assessed by patient-reported outcome measures in oncology research
Purpose The U.S. Food & Drug Administration has identified physical functioning (PF) as a core patient-reported outcome (PRO) in cancer clinical trials. The purpose of this study was to identify PF PRO measures (PROMs) in adult cancer populations and classify the PROMs by content covered (facets of PF) in each measure. Methods As part of the Patient Reports of Physical Functioning Study (PROPS) research program, we conducted a targeted literature review to identify PROMs that could be used in clinical trials to evaluate PF from the patient perspective. Next, we convened an advisory panel to conduct a modified, reactive, Delphi study to reach consensus on which PF facets are assessed by PROMs identified in the review. The panel engaged in a “card sort” activity to classify PROM items by PF facets. Consensus was reached when 80% of panel members agreed that at least one facet was being measured by each PROM item. Results The literature review identified 13 PROMs that met inclusion criteria. Eight facets of PF were identified for classification in the Delphi study: ability, completion, difficulty, limitation, quality, frequency, bother, and satisfaction. Through two rounds, the panel documented and classified conceptual approaches for each PRO item presented. The most prevalent PF facets were ability, difficulty, and limitation. Conclusion Classifying PF PROMs by PF facets will promote more consistent communication regarding the aspects of PF represented in each PROM, helping researchers prioritize measures for inclusion in cancer clinical trials.
- 20 April 2024
- Published by Springer Nature in Quality of Life Research
- Vol. 33 (7) , 1819-1828
Facets of physical function assessed by patient-reported outcome measures in oncology research
Purpose The U.S. Food & Drug Administration has identified physical functioning (PF) as a core patient-reported outcome (PRO) in cancer clinical trials. The purpose of this study was to identify PF PRO measures (PROMs) in adult cancer populations and classify the PROMs by content covered (facets of PF) in each measure. Methods As part of the Patient Reports of Physical Functioning Study (PROPS) research program, we conducted a targeted literature review to identify PROMs that could be used in clinical trials to evaluate PF from the patient perspective. Next, we convened an advisory panel to conduct a modified, reactive, Delphi study to reach consensus on which PF facets are assessed by PROMs identified in the review. The panel engaged in a “card sort” activity to classify PROM items by PF facets. Consensus was reached when 80% of panel members agreed that at least one facet was being measured by each PROM item. Results The literature review identified 13 PROMs that met inclusion criteria. Eight facets of PF were identified for classification in the Delphi study: ability, completion, difficulty, limitation, quality, frequency, bother, and satisfaction. Through two rounds, the panel documented and classified conceptual approaches for each PRO item presented. The most prevalent PF facets were ability, difficulty, and limitation. Conclusion Classifying PF PROMs by PF facets will promote more consistent communication regarding the aspects of PF represented in each PROM, helping researchers prioritize measures for inclusion in cancer clinical trials.